Control | Niacin | Pvalue | |
---|---|---|---|
n = 12 | n = 13 | (ANOVA) | |
Relative mRNA level (fold of control) | |||
Fatty acid utilization | |||
CACT | 1.00 ± 0.43 | 1.55 ± 0.62 | 0.038 |
FATP1 | 1.00 ± 0.31 | 1.33 ± 0.27 | 0.020 |
OCTN2 | 1.00 ± 0.31 | 1.44 ± 0.44 | 0.018 |
Citrate cycle | |||
SDHA | 1.00 ± 0.34 | 1.53 ± 0.58 | 0.037 |
Oxidative phosphorylation | |||
COX4/1 | 1.00 ± 0.28 | 1.40 ± 0.45 | 0.033 |
COX6A1 | 1.00 ± 0.36 | 1.57 ± 0.62 | 0.022 |
Thermogenesis | |||
UCP2 | 1.00 ± 0.63 | 1.53 ± 0.84 | 0.130 |
UCP3 | 1.00 ± 0.45 | 1.46 ± 0.49 | 0.036 |